Dual-probe digital droplet PCR strategy for specific detection of tissue-specific circulating DNA molecules
AssigneesYissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services and Development Ltd.
InventorsYuval Dor, Ruth Shemer, Benjamin Glaser, Judith Magenheim
Life of this patent
Estimating the term…
Abstract
A digital droplet PCR method of analyzing the methylation status of methylation sites of a double-stranded DNA molecule which comprises at least two methylation sites per single strand of the double-stranded DNA molecule is disclosed.
Claims14
A method of analyzing the methylation status of methylation sites of a double-stranded DNA molecule which comprises at least two methylation sites per single strand of said double-stranded DNA molecule, the double-stranded DNA molecule being comprised in a specimen, the method comprising:
- (a) contacting the double-stranded DNA with bisulfite to generate single-stranded DNA molecules of which demethylated cytosines of said single-stranded DNA molecules are converted to uracils;
- (b) fractionating the specimen into a plurality of specimen fractions wherein more than 50% of the fractions contain no more than one single-stranded DNA molecule per specimen fraction;
- (c) contacting said single-stranded DNA with amplification primers under conditions that generate amplified DNA from said single-stranded DNA;
- and
- (d) determining the methylation status of said at least two methylation sites of said single-stranded DNA molecule in at least one of said specimen fractions, wherein a methylation status of each of said at least two methylation sites on said single-stranded DNA molecule is indicative of the methylation status of methylation sites of a double-stranded DNA molecule;
- wherein said determining comprises contacting said amplified DNA with:
- (i) a first probe that hybridizes to said amplified DNA at a site which comprises the first of said at least two methylation sites;
- and
- (ii) a second probe that hybridizes to said amplified DNA at a site which comprises a second of said at least two methylation sites, wherein said first probe and said second probe are labeled with non-identical detectable moieties.
Dependencies are inferred from the claim text.